Equity Profile

AEHR

Aehr Test Systems, Inc.

Information TechnologySemiconductor Materials & Equipment$2.1B

Jul14Tue

Pre-Earnings Brief

UpcomingQ4-2026After Close5:00 PM EDT

Company Snapshot

Aehr Test Systems, Inc. (AEHR) operates in the semiconductor materials and equipment sector, focusing on testing solutions for semiconductor manufacturers....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and performance, and this quarter, AEHR is expected to report a slight loss.

$-0.01

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its testing solutions.

$19M

Wall Street expectations, options signals, track record, and call prep available with Pro.

AEHR Q4-2026 Earnings Preview

Context

Company Snapshot

Aehr Test Systems, Inc. (AEHR) operates in the semiconductor materials and equipment sector, focusing on testing solutions for semiconductor manufacturers. As the demand for advanced electronics continues to rise, their technology plays a crucial role in ensuring the reliability and performance of semiconductor devices.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+315.33%

Avg Stock Reaction

-1.34%

Last Quarter Recap

In Q3-2026, AEHR reported an EPS of $-0.05, outperforming estimates by 64.29%. However, revenue details were not disclosed, and the stock fell 3.66% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect AEHR to report a slight loss in EPS this quarter, with revenues anticipated to be around $19 million. The market will be closely watching for any signs of recovery or growth.

Bull Case

If AEHR can exceed revenue expectations and narrow its losses, it may signal a turnaround in demand for its testing solutions, potentially boosting investor confidence.

Bear Case

Conversely, if the company fails to meet revenue expectations or reports wider losses, it could raise concerns about its market position and future growth prospects.

Key Metrics to Watch

EPS

$-0.01

Earnings per share is a key indicator of profitability and performance, and this quarter, AEHR is expected to report a slight loss.

Revenue

$19M

Revenue figures will provide insight into the company's sales performance and market demand for its testing solutions.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will AEHR's revenue exceed the $19 million consensus estimate?

Meeting or exceeding revenue expectations could indicate strong demand for their testing solutions, positively impacting investor sentiment.

What is the company's outlook on profitability given the expected EPS of $-0.01?

Insights into profitability will help investors gauge the company's financial health and future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating AEHR's ability to capitalize on the growing semiconductor market, as recent trends suggest increased demand for testing solutions.

Supporting Evidence

The options market is pricing a 39.93% move, indicating high volatility that may not align with historical performance.

Insider selling of $13.2 million could suggest a lack of confidence in near-term performance, contrasting with bullish market sentiment.

Key Risk

If AEHR reports revenue below $17 million, it could challenge the optimistic outlook and lead to a reassessment of growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether AEHR can recover from recent losses and capitalize on growing demand in the semiconductor sector.

Bull Confirmed If

Revenue growth exceeding $19 million with a narrower loss than expected would confirm a positive outlook.

Bear Confirmed If

A revenue figure below $17 million or a wider loss would reinforce bearish sentiment.

Pre-Earnings Positioning

Options Market

Implied Move

±39.93%

Historical Avg

±3.2%

Pricing rich

The options market is pricing in a significant potential movement in AEHR's stock, indicating high uncertainty ahead of the earnings report.

Options are pricing ±39.9% while AEHR has averaged ±3.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.4%

30d HV

114.5%

Calls (130K)P/C Ratio: 0.93Puts (244K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If AEHR beats expectations, history suggests the stock could see a positive reaction, averaging a 2.03% increase on such news.

In-Line / Cautious

If results are in line but cautious commentary is provided, the stock may experience a muted reaction as investors digest the implications.

Miss

A miss on earnings could lead to a significant drop, with historical patterns indicating a potential average decline of around 3.24%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive revenue growth.
2Insights into the company's cost management strategies and their impact on profitability.
3Comments on market demand trends for semiconductor testing solutions.
4Any guidance on future quarters and expected recovery in sales.
5Management's perspective on competitive pressures in the semiconductor testing market.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Fastenal Company

Company Snapshot

Aehr Test Systems, Inc. (AEHR) operates in the semiconductor materials and equipment sector, focusing on testing solutions for semiconductor manufacturers....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and performance, and this quarter, AEHR is expected to report a slight loss.

$-0.01

Revenue

Revenue figures will provide insight into the company's sales performance and market demand for its testing solutions.

$19M

Wall Street expectations, options signals, track record, and call prep available with Pro.

AEHR Q4-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+315.33%

Avg Stock Reaction

-1.34%

Last Quarter Recap

In Q3-2026, AEHR reported an EPS of $-0.05, outperforming estimates by 64.29%. However, revenue details were not disclosed, and the stock fell 3.66% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect AEHR to report a slight loss in EPS this quarter, with revenues anticipated to be around $19 million. The market will be closely watching for any signs of recovery or growth.

Bull Case

If AEHR can exceed revenue expectations and narrow its losses, it may signal a turnaround in demand for its testing solutions, potentially boosting investor confidence.

Bear Case

Conversely, if the company fails to meet revenue expectations or reports wider losses, it could raise concerns about its market position and future growth prospects.

Key Metrics to Watch

EPS

$-0.01

Earnings per share is a key indicator of profitability and performance, and this quarter, AEHR is expected to report a slight loss.

Revenue

$19M

Revenue figures will provide insight into the company's sales performance and market demand for its testing solutions.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will AEHR's revenue exceed the $19 million consensus estimate?

Meeting or exceeding revenue expectations could indicate strong demand for their testing solutions, positively impacting investor sentiment.

What is the company's outlook on profitability given the expected EPS of $-0.01?

Insights into profitability will help investors gauge the company's financial health and future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating AEHR's ability to capitalize on the growing semiconductor market, as recent trends suggest increased demand for testing solutions.

Supporting Evidence

The options market is pricing a 39.93% move, indicating high volatility that may not align with historical performance.

Insider selling of $13.2 million could suggest a lack of confidence in near-term performance, contrasting with bullish market sentiment.

Key Risk

If AEHR reports revenue below $17 million, it could challenge the optimistic outlook and lead to a reassessment of growth potential.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether AEHR can recover from recent losses and capitalize on growing demand in the semiconductor sector.

Bull Confirmed If

Revenue growth exceeding $19 million with a narrower loss than expected would confirm a positive outlook.

Bear Confirmed If

A revenue figure below $17 million or a wider loss would reinforce bearish sentiment.

Pre-Earnings Positioning

Options Market

Implied Move

±39.93%

Historical Avg

±3.2%

Pricing rich

The options market is pricing in a significant potential movement in AEHR's stock, indicating high uncertainty ahead of the earnings report.

Options are pricing ±39.9% while AEHR has averaged ±3.2% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

1.4%

30d HV

114.5%

Calls (130K)P/C Ratio: 0.93Puts (244K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If AEHR beats expectations, history suggests the stock could see a positive reaction, averaging a 2.03% increase on such news.

In-Line / Cautious

If results are in line but cautious commentary is provided, the stock may experience a muted reaction as investors digest the implications.

Miss

A miss on earnings could lead to a significant drop, with historical patterns indicating a potential average decline of around 3.24%.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new contracts or partnerships that could drive revenue growth.
2Insights into the company's cost management strategies and their impact on profitability.
3Comments on market demand trends for semiconductor testing solutions.
4Any guidance on future quarters and expected recovery in sales.
5Management's perspective on competitive pressures in the semiconductor testing market.